insights_auto
Outlook: 66.7% bullish·0.0% bearish
Go to analysischevron_right
MLYS:NASDAQ
Mineralys Therapeutics Inc
၁၅.၅၂ US$
arrow_downward
-၁.၈၃%(-၀.၂၉) 1D
၁၅.၆၉ US$
arrow_upward
+၁.၁၀% (+၀.၁၇)todayPre-market
Closed: နို ၁၀, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MLYS...
Open
၁၅.၄၈ US$
High
၁၆.၅၂ US$
Low
၁၅.၀၅ US$
Mkt. cap
၁၃၇.၄၄ ဋေ
Avg. vol.
၁.၇၇ သန်း
Volume
၁၀၃.၀၀
52-wk high
၄၇.၆၅ US$
52-wk low
၁၄.၉၅ US$
EPS
-၄.၃၆ US$
Beta
၀.၈၃
Shares outstanding
၈.၈၆ ကုဋေ
No. of employees
၇၆
Open
၁၅.၄၈ US$
High
၁၆.၅၂ US$
Low
၁၅.၀၅ US$
Mkt. cap
၁၃၇.၄၄ ဋေ
Avg. vol.
၁.၇၇ သန်း
Volume
၁၀၃.၀၀
52-wk high
၄၇.၆၅ US$
52-wk low
၁၄.၉၅ US$
EPS
-၄.၃၆ US$
Beta
၀.၈၃
Shares outstanding
၈.၈၆ ကုဋေ
No. of employees
၇၆
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၁၁ နာရီ
Mineralys at Guggenheim healthcare conference: launch prep in focus
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Mineralys stock gains after drug shows sustained blood pressure cuts
GuruFocus
·
ပြီးခဲ့သည့် ၂ ရက်
Mineralys Therapeutics (MLYS) Reports Promising Long-Term Data on Lorundrostat for Resistant Hypertension
About Mineralys Therapeutics Inc